Skip to main content
. 2018 May 30;8:8434. doi: 10.1038/s41598-018-26501-6

Figure 3.

Figure 3

HMGB1 induced TGF-β1, Smads, Erk 1/2, Akt, and NF-κb in HDFs. (ac) Effects of HMGB1 on TGF-β1 signaling pathway in vitro. Significant increases in the expression levels of TGF-β1, Smad 2, and Smad 3 mRNA were observed in the HMGB1 (50 ng)-treated HDFs (**p < 0.01). (d) Effects of HMGB1 on TGF-β and phosphor-Smad 2/3 complex protein expressions. (e,f) TGF-β and phosphor-Smad 2/3 complex protein levels were significantly increased in the HMGB1 (100 ng)-treated HDFs (**p < 0.01). (g) Western blotting analysis in normal dermal spheroids. Increased expression of TGF-β and phosphor-Smad 2/3 complex protein were observed in normal dermal spheroids treated with HMGB1 (400 ng and 1000 ng). (h) The levels of Erk 1/2, Akt, and NF-κb protein were detected by western blotting in HDFs lysates treated with HMGB1 (50 ng and 100 ng). (i to k) Erk 1/2, Akt, and NF-κb protein levels in HMGB1 (100 ng)-treated HDFs were significantly increased by 1.5-, 2.0-, and 2.3-fold, respectively, versus non-treated HDFs (**p < 0.01).